Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgG Deficiency”

48 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 48 results

Not applicableStudy completedNCT03369301
What this trial is testing

The Effect of Subcutaneous Immunoglobulin Gammanorm on the Distribution of IgG Subclasses and on Immunity of Patients With Secondary Immunodeficiency

Who this might be right for
Secondary Immune Deficiency
Octapharma 102
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Large-scale testing (Phase 3)Study completedNCT00419341
What this trial is testing

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

Who this might be right for
Primary Immune Deficiency
CSL Behring 49
Not applicableUnknownNCT01646411
What this trial is testing

300 Antibody Diagnostic Test Kit

Who this might be right for
Acute Bacterial InfectionsAcute Viral Infections
The Plasma Source 300
Large-scale testing (Phase 3)Study completedNCT00168012
What this trial is testing

Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)

Who this might be right for
AgammaglobulinemiaIgG DeficiencyCommon Variable Immunodeficiency
CSL Behring 42
Not applicableStudy completedNCT06355323
What this trial is testing

Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France

Who this might be right for
Primary ImmunodeficiencyCommon Variable ImmunodeficiencyIgg Subclass Deficiency+1 more
CHU de Reims 46
Testing effectiveness (Phase 2)Study completedNCT01847781
What this trial is testing

PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency

Who this might be right for
IgG Deficiency
Karolinska University Hospital 20
Post-approval studies (Phase 4)Study completedNCT02881437
What this trial is testing

IgG Level in Primary Immunodeficiency Switching From Standard SCIG to Every Other Week HyQvia

Who this might be right for
Primary Immunodeficiency
University Hospital, Lille 22
Not applicableLooking for participantsNCT06065852
What this trial is testing

National Registry of Rare Kidney Diseases

Who this might be right for
Adenine Phosphoribosyltransferase DeficiencyAH AmyloidosisAHL Amyloidosis+81 more
UK Kidney Association 35,000
Large-scale testing (Phase 3)Study completedNCT01199705
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 25
Early research (Phase 1)Study completedNCT00000663
What this trial is testing

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 Immunoglobulin G (rCD4-IgG) in Infants and Children With Documented HIV-1 Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 18
Early research (Phase 1)Study completedNCT00000876
What this trial is testing

Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT00000647
What this trial is testing

An Open Trial Combining Zidovudine, Interferon-alfa, and Recombinant CD4-IgG With Transplantation of Syngeneic Bone Marrow and Peripheral Blood Lymphocytes From Healthy gp160-Immunized Donors in the Treatment of Patients With HIV Infection

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 6
Large-scale testing (Phase 3)Study completedNCT00542997
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy

Who this might be right for
Common Variable ImmunodeficiencyX-linked AgammaglobulinemiaAutosomal Recessive Agammaglobulinemia
CSL Behring 51
Post-approval studies (Phase 4)WithdrawnNCT03737617
What this trial is testing

Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis

Who this might be right for
BronchiectasisImmunoglobulin Subclass Deficiency
University of Edinburgh
Large-scale testing (Phase 3)Active Not RecruitingNCT04944979
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 30
Large-scale testing (Phase 3)Study completedNCT01458171
What this trial is testing

Follow-up Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency Disorder
CSL Behring 23
Not applicableStudy completedNCT01166074
What this trial is testing

Retrospective Chart Review of Subcutaneous IgG Use in Infants

Who this might be right for
Primary Immune Deficiency
CSL Behring 27
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06590545
What this trial is testing

Anti-CD 19 CAR-T Cell Therapy in Patients With ANCA Vasculitis

Who this might be right for
ANCA-IgG-positive ANCA Associated Vasculitis
David Simon 8
Post-approval studies (Phase 4)Study completedNCT03164967
What this trial is testing

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Who this might be right for
Humoral Immune Response
ADMA Biologics, Inc. 16
Load More Results